Clinical trial
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
NCT00366379 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00366379 |
|---|---|
| Title | A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes. |
| Official title | An Open Label Study to Determine the Effect on Fasting Glucose Levels, and Safety, of Increasing Doses of GK Activator (2) in Patients With Type 2 Diabetes Not Optimally Controlled With One Previous Oral Antihyperglycemic Agent. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 2 |
| Intervention type | Drug |
| Interventions | GK Activator (2) |
| Enrollment | 127 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Aug 21, 2006 |
| Last update posted | Nov 2, 2016 |
| Countries | Estonia, Latvia, Mexico, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: